10-K Filing

REGENERON PHARMACEUTICALS, INC. CIK: 872589 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001804220-21-000008`
Period End Date	20201231
Filing Date	20210208
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	regn-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 110 Cash Flow Statement 97 Stockholders Equity 38

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.47B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.62B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.39B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.60B	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$2.10B	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$3.11B	USD	Point-in-time
Treasury Stock (in shares)	`TreasuryStockShares`	16.43M	shares	Point-in-time
Treasury Stock (in shares)	`TreasuryStockShares`	4.86M	shares	Point-in-time
Inventories	`InventoryNet`	$1.92B	USD	Point-in-time
Inventories	`InventoryNet`	$1.42B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$273.70M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$160.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.69B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.78B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$3.14B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$3.26B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$3.22B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.89B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$824.20M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$858.90M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$168.10M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$144.70M	USD	Point-in-time
Total assets	`Assets`	$17.16B	USD	Point-in-time
Total assets	`Assets`	$14.81B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$475.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$418.10M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.52B	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.21B	USD	Point-in-time
Other liabilities - Sanofi	`OtherLiabilitiesCurrent`	$85.00M	USD	Point-in-time
Other liabilities - Sanofi	`OtherLiabilitiesCurrent`	$122.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.70B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.10B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.98B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$713.90M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$717.20M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.14B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.72B	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$6.72B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$10.89B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.38B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.10M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$29.30M	USD	Point-in-time
Treasury Stock, at cost; 16,431,520 shares in 2020 and 4,860,123 shares in 2019	`TreasuryStockValue`	$6.61B	USD	Point-in-time
Treasury Stock, at cost; 16,431,520 shares in 2020 and 4,860,123 shares in 2019	`TreasuryStockValue`	$739.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.14B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.76B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.03B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.09B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.81B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.16B	USD	Point-in-time

Income Statement 110 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.37B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.74B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.58B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.95B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.29B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.83B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.50B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.15B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.86B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.56B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.42B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.45B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.73B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.47B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.13B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.34B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.35B	USD	Annual
Cost of goods sold and of collaboration and contract manufacturing	`CostOfGoodsAndServicesSold`	$402.80M	USD	Annual
Cost of goods sold and of collaboration and contract manufacturing	`CostOfGoodsAndServicesSold`	$237.50M	USD	Annual
Other operating (income) expense, net	`OtherOperatingIncomeExpenseNet`	$402.30M	USD	Annual
Other operating (income) expense, net	`OtherOperatingIncomeExpenseNet`	$209.20M	USD	Annual
Other operating (income) expense, net	`OtherOperatingIncomeExpenseNet`	$280.40M	USD	Annual
Total expenses	`CostsAndExpenses`	$1.26B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$892.60M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.24B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$2.61B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.01B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$4.92B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.13B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.30B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.19B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$4.35B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.26B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$2.53B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$3.58B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.21B	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$249.50M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$47.30M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$290.70M	USD	Annual
Interest expense	`InterestExpense`	$28.20M	USD	Annual
Interest expense	`InterestExpense`	$30.20M	USD	Annual
Interest expense	`InterestExpense`	$56.90M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$19.10M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$233.80M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$219.30M	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.81B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.43B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.55B	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$297.20M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$109.10M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$313.30M	USD	Annual
Net income	`NetIncomeLoss`	$3.51B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$624.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.15B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$842.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$897.30M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$7.25	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$4.23	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$22.65	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$1.77	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$5.69	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$7.98	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$19.38	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$32.65	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$8.19	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$10.90	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$6.12	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.93	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.61	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.99	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.86	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$30.52	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$21.29	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.39	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.68	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$18.46	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.43	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$10.24	USD	1 Quarter
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	109.20M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.90M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.60M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	114.80M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	114.60M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.10M	shares	Annual
Net income	`NetIncomeLoss`	$3.51B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$624.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.15B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$842.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$897.30M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Unrealized gain (loss) on debt securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.10M	USD	Annual
Unrealized gain (loss) on debt securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$35.90M	USD	Annual
Unrealized gain (loss) on debt securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-7.00M	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$700.00K	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-2.50M	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-900.00K	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.44B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.15B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$3.52B	USD	Annual

Cash Flow Statement 97 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$3.51B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$624.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.15B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$842.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$897.30M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$210.30M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$148.20M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$235.90M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$464.30M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$432.00M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$427.40M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-12.10M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$135.00M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$29.30M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-75.60M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$130.60M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$140.00M	USD	Annual
Increase in trade, Sanofi, and other accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$523.70M	USD	Annual
Increase in trade, Sanofi, and other accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.36B	USD	Annual
Increase in trade, Sanofi, and other accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$236.40M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$387.90M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$529.40M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$335.50M	USD	Annual
Decrease (increase) in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-114.90M	USD	Annual
Decrease (increase) in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$88.10M	USD	Annual
Decrease (increase) in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$79.80M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-43.40M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$139.50M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$148.10M	USD	Annual
Increase in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$58.80M	USD	Annual
Increase in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$118.90M	USD	Annual
Increase in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$599.00M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$314.20M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-895.10M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-249.30M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.43B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.20B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.62B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$1.85B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$3.24B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$3.20B	USD	Annual
Sales or maturities of marketable and other securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.79B	USD	Annual
Sales or maturities of marketable and other securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.60B	USD	Annual
Sales or maturities of marketable and other securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$775.60M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$383.10M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$429.60M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$614.60M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$10.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.03B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.60M	USD	Annual
Proceeds from issuance of long-term debt, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.98B	USD	Annual
Proceeds from issuance of long-term debt, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from issuance of long-term debt, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from bridge loan facility	`ProceedsFromShortTermDebt`	-	USD	Annual
Proceeds from bridge loan facility	`ProceedsFromShortTermDebt`	$1.50B	USD	Annual
Proceeds from bridge loan facility	`ProceedsFromShortTermDebt`	-	USD	Annual
Repayment of bridge loan facility	`RepaymentsOfShortTermDebt`	$1.50B	USD	Annual
Repayment of bridge loan facility	`RepaymentsOfShortTermDebt`	-	USD	Annual
Repayment of bridge loan facility	`RepaymentsOfShortTermDebt`	-	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$211.80M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$2.58B	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$114.50M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$188.00M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$680.80M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$4.40M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$5.85B	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$275.90M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-77.10M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.97B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-252.10M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$577.00M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$150.10M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$655.00M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.21B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.21B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$25.00M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$23.20M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$22.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$205.60M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$342.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$188.10M	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$11.03B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$11.09B	USD	Point-in-time
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$114.20M	USD	Annual
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.58B	USD	Annual
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$213.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$188.00M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$768.90M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$26.90M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$38.10M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$44.70M	USD	Annual
Repurchases of Common Stock	`StockRepurchasedDuringPeriodValue`	$80.20M	USD	Annual
Repurchases of Common Stock	`StockRepurchasedDuringPeriodValue`	$356.70M	USD	Annual
Repurchases of Common Stock	`StockRepurchasedDuringPeriodValue`	$5.88B	USD	Annual
Conversion of Class A Stock to Common Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$444.80M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$466.90M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$442.90M	USD	Annual
Net income	`NetIncomeLoss`	$3.51B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$624.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.15B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$842.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$897.30M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$8.20M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.40M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-6.30M	USD	Annual
Ending Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$11.03B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$11.09B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.